Your new post is loading...
Scooped by Beeyond
Scoop.it!

Multimodality imaging for preprocedural planning of percutaneous mitral valve repair: a comprehensive review

Multimodality imaging for preprocedural planning of percutaneous mitral valve repair: a comprehensive review | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

Echocardiography, cardiac magnetic resonance (CMR), and cardiac computed tomography (CT) may provide complementary information to guide patient and device selection. Evaluation of mitral valve anatomy, identification of MV lesion, and quantification of defect severity should be integrated by comprehensive preprocedural assessment of chamber size, biventricular systolic and diastolic function, hemodynamic impact, and aortic or peripheral vascular disease.

No comment yet.
Scooped by Beeyond
Scoop.it!

In-Hospital Outcomes and Predictors of Mortality for Redo Surgical Mitral Valve Replacement Versus Transcatheter Mitral Valve-in-Valve Replacement

In-Hospital Outcomes and Predictors of Mortality for Redo Surgical Mitral Valve Replacement Versus Transcatheter Mitral Valve-in-Valve Replacement | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

Durability is a major limitation with bioprosthetic heart valves. For mitral valve prosthesis dysfunction, redo surgical mitral valve replacement (rSMVR) has been the mainstay of treatment; however, transcatheter mitral valve-in-valve replacement (mViV) has emerged as a viable alternative. Data comparing these procedures remains limited; therefore, we sought to compare the real-world in-hospital mortality, likelihood of adverse peri-operative outcomes, and predictors of mortality between rSMVR versus mViV using the National Inpatient Sample.

No comment yet.
Scooped by Beeyond
Scoop.it!

Prosthetic heart valves: Part 1 – Selection

Prosthetic heart valves: Part 1 – Selection | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

In patients with severe valvular heart disease, guideline-based surgical valve replacement or transcatheter implantation of a prosthetic heart valve is associated with improved survival and relief of symptoms. Prosthetic heart valves are designed to replicate the function of native valves by maintaining unidirectional blood flow and can be separated into two broad categories, mechanical and bioprosthetic (also called tissue) valves, each with different advantages and disadvantages.

No comment yet.
Scooped by Beeyond
Scoop.it!

Prosthetic heart valves: Part 2 - Antithrombotic management

Prosthetic heart valves: Part 2 - Antithrombotic management | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

In patients with severe valvular heart disease, guideline-based surgical valve replacement or transcatheter implantation of a prosthetic heart valve is associated with improved survival and relief of symptoms. Prosthetic heart valves are designed to replicate the function of native valves by maintaining unidirectional blood flow and can be separated into two broad categories, mechanical and bioprosthetic (also called tissue) valves, each with different advantages and disadvantages.

No comment yet.
Scooped by Beeyond
Scoop.it!

Prosthetic heart valves: Part 3 – Imaging

Prosthetic heart valves: Part 3 – Imaging | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

In patients with severe valvular heart disease, guideline-based surgical valve replacement or transcatheter implantation of a prosthetic heart valve is associated with improved survival and relief of symptoms. Prosthetic heart valves are designed to replicate the function of native valves by maintaining unidirectional blood flow and can be separated into two broad categories, mechanical and bioprosthetic (also called tissue) valves, each with different advantages and disadvantages.

No comment yet.
Scooped by Beeyond
Scoop.it!

Prosthetic heart valves: Part 4 – Complications and dysfunction, pregnancy

Prosthetic heart valves: Part 4 – Complications and dysfunction, pregnancy | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

In patients with severe valvular heart disease, guideline-based surgical valve replacement or transcatheter implantation of a prosthetic heart valve is associated with improved survival and relief of symptoms. Prosthetic heart valves are designed to replicate the function of native valves by maintaining unidirectional blood flow and can be separated into two broad categories, mechanical and bioprosthetic (also called tissue) valves, each with different advantages and disadvantages.

No comment yet.
Scooped by Beeyond
Scoop.it!

Transseptal Courses

Transseptal Courses | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

Advance your transseptal skillset for structural heart procedures with the technical and clinical guidance of expert faculty. These courses provide didactic and hands-on training designed for Interventional Cardiologists who perform complex left heart procedures, such as mitral valve repair and LAA occlusion.

No comment yet.
Scooped by Beeyond
Scoop.it!

Follow-Up of Robotic Mitral Valve Repair: A Single Tertiary Institution Experience in China

Follow-Up of Robotic Mitral Valve Repair: A Single Tertiary Institution Experience in China | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

Surgical treatment of mitral valve diseases has become minimally invasive. This study analyzed the follow-up results of patients after mitral valve repairs (MVRep) using the da Vinci robot.

No comment yet.
Scooped by Beeyond
Scoop.it!

Beating Heart Mitral Valve Repair System

Beating Heart Mitral Valve Repair System | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

This broadcast brings together an international faculty to discuss the timely treatment of Degenerative Mitral Valve Regurgitation (DMR) in patients in Europe. Highlighting the most innovative and advanced treatment strategies this programme will provide focus on breakthrough therapy and the program of HARPOON Mitral Valve Repair System including a Live in a Box case introduced by Prof Nicolas Doll.

No comment yet.
Scooped by Beeyond
Scoop.it!

Transcatheter mitral valve repair may benefit in secondary MR outside current indication

Transcatheter mitral valve repair may benefit in secondary MR outside current indication | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

Certain patients with HF and secondary mitral regurgitation outside the current indication for transcatheter mitral valve repair benefited from the procedure, according to results of the MitraClip Global EXPAND Study.

No comment yet.
Scooped by Beeyond
Scoop.it!

Cerebral embolism during transcatheter mitral valve repair: not so silent after all?

Cerebral embolism during transcatheter mitral valve repair: not so silent after all? | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

The risk of liberating embolic debris is inherent to most, if not all, structural heart interventions. Large-bore device placement within the heart chambers, particularly via a transseptal or transaortic approach, and substantial interaction with cardiac structures may release acute or chronic thrombus, cardiac tissue, and device-related material into the bloodstream. One major consequence, cerebral embolism, is one of the most dreadful periprocedural complications of left-sided structural heart interventions. Ongoing research on cerebral embolic protection devices aims to further improve outcome in patients undergoing transcatheter aortic valve replacement (TAVR)1.

No comment yet.
Scooped by Beeyond
Scoop.it!

Guideline-directed medical therapy after transcatheter edge-to-edge mitral valve repair

Guideline-directed medical therapy after transcatheter edge-to-edge mitral valve repair | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

GDMT, defined as triple therapy consisting of beta-blockers, RAS inhibitors and MRAs, was associated with a reduced risk of 2-year mortality after TEER for SMR. Optimisation of medical therapy is crucial to improve clinical outcomes in patients undergoing TEER for SMR.

No comment yet.
Scooped by Beeyond
Scoop.it!

ENCIRCLE Trial HCP - Edwards Lifesciences

ENCIRCLE Trial HCP - Edwards Lifesciences | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

Mitral regurgitation (MR) etiology can be categorized into primary or secondary. In primary MR (also knows as degenerative), there is an abnormality in one or more components of the mitral apparatus (leaflets, annulus, chordae tendineae, papillary muscles). In secondary MR (also known as functional), the valve itself is usually normal but mitral insufficiency arises from alterations in left ventricular (LV) geometry.

No comment yet.
Scooped by Beeyond
Scoop.it!

Transcatheter mitral valve repair safe, effective for patients with COPD

Transcatheter mitral valve repair safe, effective for patients with COPD | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

The presence of chronic obstructive pulmonary disease is not associated with intra-hospital or 1-year outcomes for patients with mitral regurgitation undergoing transcatheter mitral valve repair, data from a single-center study show.

No comment yet.
Scooped by Beeyond
Scoop.it!

Top Mitral Valve Repair Surgeons of India Offering Viable Option

Top Mitral Valve Repair Surgeons of India Offering Viable Option | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

With several years of experience in treating valve defects and problems, the Top mitral valve repair surgeons of India offer a high success rate along with the best service. The mitral valve repair surgery success rate in India is very high, and they have sent numerous successfully recovered happy patients home with total satisfaction. After mitral valve repair in India, 95% of sufferers are free of reoperation at 10 years, and this determines about 90% at 25 years.

No comment yet.
Scooped by Beeyond
Scoop.it!

Johns Hopkins Joins Cardiothoracic Surgical Trials Network

Johns Hopkins Joins Cardiothoracic Surgical Trials Network | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

The network is an international consortium, sponsored by the National Heart, Lung and Blood Institute, that provides infrastructure for proof-of-concept studies and interventions to improve outcomes for patients with cardiovascular disease. It is supported by the National Institutes of Health and other research organizations in the United States, Canada and Germany.

No comment yet.
Scooped by Beeyond
Scoop.it!

Two Cases of Arrhythmic Mitral Valve Prolapse: Evil Has Many Faces

Two Cases of Arrhythmic Mitral Valve Prolapse: Evil Has Many Faces | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

The association of MVP and SCD is supported by several clinical, electrocardiographic, and imaging findings. However, there is no single risk marker, nor any specific combination of them, that has proved to be a consistent predictor of malignant VAs and SCD in patients with MVP. Therefore, further research is needed to validate the existing risk markers, improve our understanding of the underlying arrhythmogenic mechanisms, and establish optimal evidence-based treatment strategies.

No comment yet.
Scooped by Beeyond
Scoop.it!

Percutaneous mitral valve repair in adults with congenital heart disease: Report of the first case‐series

Percutaneous mitral valve repair in adults with congenital heart disease: Report of the first case‐series | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

Percutaneous atrioventricular valve repair in adults with CHD is feasible with the MitraClip but requires significant preprocedural planning and a multidisciplinary team that combines CHD and interventional therapeutic expertise.

No comment yet.
Scooped by Beeyond
Scoop.it!

One-Year Outcomes of Early, Compassionate Use of the PASCAL Ace Implant System for Transcatheter Mitral Valve Repair

One-Year Outcomes of Early, Compassionate Use of the PASCAL Ace Implant System for Transcatheter Mitral Valve Repair | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

At 1 year, the PASCAL Ace implant system demonstrated feasibility in this early, compassionate use experience in a small group of symptomatic patients with anatomically complex MR. The unique features of the PASCAL Ace implant may expand the treatable MR population.

No comment yet.
Scooped by Beeyond
Scoop.it!

Balloon-Assisted Perclose Suture Delivery for Large-Bore Vascular Access Closure After Transcatheter Aortic Valve Replacement

Balloon-Assisted Perclose Suture Delivery for Large-Bore Vascular Access Closure After Transcatheter Aortic Valve Replacement | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

Balloon-assisted Perclose suture delivery facilitates successful vascular closure following large-bore access. Use of a balloon in the CFA provides counterpressure to assist delivery of the sliding suture knot and a fluoroscopic marker to confirm that the suture has been delivered to the vessel wall.

No comment yet.
Scooped by Beeyond
Scoop.it!

Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation

Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

In this landmark analysis of the MITRA-FR trial, the cumulative rate of HF hospitalisation between 12 and 24 months among patients treated with TMVR on top of GDMT was approximately half as many as those of patients treated with GDMT alone, a difference which did not reach statistical significance in the setting of a low number of events.

No comment yet.
Scooped by Beeyond
Scoop.it!

Gamification in Healthcare to Drive the Transcatheter Heart Valve Replacement Repair Market

Gamification in Healthcare to Drive the Transcatheter Heart Valve Replacement Repair Market | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

The global Transcatheter Heart Valve Replacement Repair Market is expected to stimulate at a good rate In Upcoming Years. Virtual consultations are amongst the ongoing trends. They mitigate the spreading of contagious ailments, thereby facilitating better efficiency. The gap regarding the demand-supply ratio could also be bridged this way. With this practice being followed, the developing economies would benefit better, as the cost to commute could be curtailed.

No comment yet.
Scooped by Beeyond
Scoop.it!

What's The Latest Update For Non-Invasive TMVR?

What's The Latest Update For Non-Invasive TMVR? | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

The impact of transcatheter aortic valve replacement (TAVR) for aortic stenosis patients has been revolutionary during the past 10 years. TAVR does not require an incision to the patient’s chest or ribs. A TAVR procedure does not require the use of the heart-lung machine. And, TAVR patients are often in the hospital for only one day. With the success of TAVR, patients with mitral valve disease are asking questions about the use of transcatheter mitral valve repair (TMVr) and transcatheter mitral valve replacement (TMVR). For example, I just received an email from Henry who asked me, “Hi Adam, What is the latest update for transcatheter mitral valve treatments?”

No comment yet.
Scooped by Beeyond
Scoop.it!

Multicenter Clinical Management Practice to Optimize Outcomes Following Tendyne Transcatheter Mitral Valve Replacement

Multicenter Clinical Management Practice to Optimize Outcomes Following Tendyne Transcatheter Mitral Valve Replacement | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

The TendyneTM transcatheter mitral valve replacement system (Tendyne-TMVR, Abbott Structural Heart, Santa Clara, California) is a therapy for patients with symptomatic mitral valve (MV) disease high risk for conventional MV surgery or challenging anatomy for transcatheter MV repair. With over 1000 Tendyne-TMVR performed worldwide and beneficial periprocedural, 30-day, and 2-year outcomes, the aim of this article is to present best practice recommendations from expert centers performing Tendyne-TMVR to support optimal outcomes (Figure 1).

No comment yet.
Scooped by Beeyond
Scoop.it!

First successful “valve-in-MAC” transcatheter mitral valve replacement

First successful “valve-in-MAC” transcatheter mitral valve replacement | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

A multidisciplinary team of interventional cardiologists and a cardiothoracic surgeon performed Louisville’s first successful transcatheter replacement of a native mitral valve this week. The team with Norton Heart & Vascular Institute Structural Heart Program used a transcatheter aortic valve (commonly referred to as TAVR) to replace the patient’s mitral valve that was unable to be treated with standard techniques.

No comment yet.
Curated by Beeyond
BEEYOND is a consulting company in the field of disruptive innovation, accompanying established companies on out-of-the-core growth strategy, from creation of new concepts to product launch. Reach us at: contact@beeyond.fr.